Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 57

1.

[Raynaud's phenomenon : Practical management for dermatologists].

Drerup C, Ehrchen J.

Hautarzt. 2019 Feb;70(2):131-141. doi: 10.1007/s00105-018-4353-9. German.

PMID:
30671625
2.

MDSCs in infectious diseases: regulation, roles, and readjustment.

Dorhoi A, Glaría E, Garcia-Tellez T, Nieuwenhuizen NE, Zelinskyy G, Favier B, Singh A, Ehrchen J, Gujer C, Münz C, Saraiva M, Sohrabi Y, Sousa AE, Delputte P, Müller-Trutwin M, Valledor AF.

Cancer Immunol Immunother. 2018 Dec 19. doi: 10.1007/s00262-018-2277-y. [Epub ahead of print]

PMID:
30569204
3.

Vitiligo after alemtuzumab treatment: Secondary autoimmunity is not all about B cells.

Ruck T, Pfeuffer S, Schulte-Mecklenbeck A, Gross CC, Lindner M, Metze D, Ehrchen J, Sondermann W, Pul R, Kleinschnitz C, Wiendl H, Meuth SG, Klotz L.

Neurology. 2018 Dec 11;91(24):e2233-e2237. doi: 10.1212/WNL.0000000000006648. Epub 2018 Nov 7.

4.

Sweet syndrome in association with enterobiasis.

Sulk M, Ehrchen J.

J Dermatol. 2018 Sep 6. doi: 10.1111/1346-8138.14615. [Epub ahead of print] No abstract available.

PMID:
30187540
5.

Ulzerierende Teleangiektasien im Gesicht und paravertebral bei einem 6-jährigen Mädchen mit erhöhtem ANA-Titer.

Drerup C, Ehrchen J, Metze D, Goerge T.

J Dtsch Dermatol Ges. 2018 Mar;16(3):368-371. doi: 10.1111/ddg.13433_g. No abstract available.

PMID:
29537171
6.

Ulcerative telangiectasia on the face and back of a 6-year-old girl with elevated antinuclear antibodies.

Drerup C, Ehrchen J, Metze D, Goerge T.

J Dtsch Dermatol Ges. 2018 Mar;16(3):368-371. doi: 10.1111/ddg.13433. Epub 2018 Jan 29. No abstract available.

PMID:
29377620
7.

Amyopathische Dermatomyositis mit Anti-TIF1-gamma-Antikörpern.

Schiffmann ML, Warneke VS, Ehrchen J.

J Dtsch Dermatol Ges. 2018 Jan;16(1):77-79. doi: 10.1111/ddg.13394_g. No abstract available.

PMID:
29314695
8.

Amyopathic dermatomyositis with anti-TIF1 gamma antibodies.

Schiffmann ML, Warneke VS, Ehrchen J.

J Dtsch Dermatol Ges. 2018 Jan;16(1):76-78. doi: 10.1111/ddg.13394. Epub 2017 Dec 12. No abstract available.

PMID:
29232033
9.

Blistering and Skin Fragility Due to Imatinib Therapy: Loss of Laminin and Collagen IV as a Possible Cause of Cutaneous Basement Membrane Instability.

Mühl S, Ehrchen J, Metze D.

Am J Dermatopathol. 2018 May;40(5):371-374. doi: 10.1097/DAD.0000000000001063.

PMID:
29210715
10.

Dengue-Fieber und die Differenzialdiagnosen zu Exanthem, Fieber und Kopfschmerzen nach Fernreise.

Tjandra ET, Ehrchen J, Broekaert S, Sunderkötter C.

J Dtsch Dermatol Ges. 2017 Jan;15(1):82-86. doi: 10.1111/ddg.12941_g. No abstract available.

PMID:
28140551
11.

Severe antiphospholipid antibody syndrome - response to plasmapheresis and rituximab.

Gkogkolou P, Ehrchen J, Goerge T.

J Dermatolog Treat. 2017 Sep;28(6):564-566. doi: 10.1080/09546634.2017.1282599. Epub 2017 Feb 1.

PMID:
28084106
12.

Dengue fever and the differential diagnoses of rash, fever, and headache following travel to the tropics.

Tjandra ET, Ehrchen J, Broekaert S, Sunderkötter C.

J Dtsch Dermatol Ges. 2017 Jan;15(1):82-85. doi: 10.1111/ddg.12941. Epub 2016 Dec 30. No abstract available.

PMID:
28036150
13.

Stevens Johnson syndrome/toxic epidermal necrolysis after exogenous contact to S,S-dimethyl cyanoimidodithiocarbonate.

Schedel F, Herrnstadt G, Ehrchen J.

J Eur Acad Dermatol Venereol. 2017 Feb;31(2):e96-e97. doi: 10.1111/jdv.13804. Epub 2016 Jul 12. No abstract available.

PMID:
27401191
14.

Activation-dependent cell death of human monocytes is a novel mechanism of fine-tuning inflammation and autoimmunity.

Däbritz J, Weinhage T, Varga G, Wirth T, Ehrchen JM, Barczyk-Kahlert K, Roth J, Schwarz T, Foell D.

Eur J Immunol. 2016 Aug;46(8):1997-2007. doi: 10.1002/eji.201545802. Epub 2016 May 27.

15.

[Neurophilic urticarial dermatosis].

Ehrchen J.

Hautarzt. 2016 May;67(5):403-13. doi: 10.1007/s00105-016-3788-0. Review. German.

PMID:
27119369
16.

Vasoactive Therapy in Systemic Sclerosis: Real-life Therapeutic Practice in More Than 3000 Patients.

Moinzadeh P, Riemekasten G, Siegert E, Fierlbeck G, Henes J, Blank N, Melchers I, Mueller-Ladner U, Frerix M, Kreuter A, Tigges C, Lahner N, Susok L, Guenther C, Zeidler G, Pfeiffer C, Worm M, Karrer S, Aberer E, Bretterklieber A, Genth E, Simon JC, Distler JH, Hein R, Schneider M, Seitz CS, Herink C, Steinbrink K, Sárdy M, Varga R, Mensing H, Mensing C, Lehmann P, Neeck G, Fiehn C, Weber M, Goebeler M, Burkhardt H, Buslau M, Ahmadi-Simab K, Himsel A, Juche A, Koetter I, Kuhn A, Sticherling M, Hellmich M, Kuhr K, Krieg T, Ehrchen J, Sunderkoetter C, Hunzelmann N; German Network for Systemic Scleroderma.

J Rheumatol. 2016 Jan;43(1):66-74. doi: 10.3899/jrheum.150382. Epub 2015 Nov 15.

17.

[Cutaneous symptoms of various vasculitides].

Sunderkötter C, Pappelbaum KI, Ehrchen J.

Hautarzt. 2015 Aug;66(8):589-98. doi: 10.1007/s00105-015-3661-6. Review. German.

PMID:
26195032
18.

Single amino acid charge switch defines clinically distinct proline-serine-threonine phosphatase-interacting protein 1 (PSTPIP1)-associated inflammatory diseases.

Holzinger D, Fassl SK, de Jager W, Lohse P, Röhrig UF, Gattorno M, Omenetti A, Chiesa S, Schena F, Austermann J, Vogl T, Kuhns DB, Holland SM, Rodríguez-Gallego C, López-Almaraz R, Arostegui JI, Colino E, Roldan R, Fessatou S, Isidor B, Poignant S, Ito K, Epple HJ, Bernstein JA, Jeng M, Frankovich J, Lionetti G, Church JA, Ong PY, LaPlant M, Abinun M, Skinner R, Bigley V, Sachs UJ, Hinze C, Hoppenreijs E, Ehrchen J, Foell D, Chae JJ, Ombrello A, Aksentijevich I, Sunderkoetter C, Roth J.

J Allergy Clin Immunol. 2015 Nov;136(5):1337-45. doi: 10.1016/j.jaci.2015.04.016. Epub 2015 May 27.

PMID:
26025129
19.

Reprogramming of monocytes by GM-CSF contributes to regulatory immune functions during intestinal inflammation.

Däbritz J, Weinhage T, Varga G, Wirth T, Walscheid K, Brockhausen A, Schwarzmaier D, Brückner M, Ross M, Bettenworth D, Roth J, Ehrchen JM, Foell D.

J Immunol. 2015 Mar 1;194(5):2424-38. doi: 10.4049/jimmunol.1401482. Epub 2015 Feb 4.

20.

Immune suppression via glucocorticoid-stimulated monocytes: a novel mechanism to cope with inflammation.

Varga G, Ehrchen J, Brockhausen A, Weinhage T, Nippe N, Belz M, Tsianakas A, Ross M, Bettenworth D, Spieker T, Wolf M, Lippe R, Tenbrock K, Leenen PJ, Roth J, Sunderkötter C.

J Immunol. 2014 Aug 1;193(3):1090-9. doi: 10.4049/jimmunol.1300891. Epub 2014 Jul 2.

21.

Acquired epidermodysplasia verruciformis in an HIV-infected patient.

Broekaert SM, Ehrchen J, Büttner R, Pfister HJ, Metze D.

J Dtsch Dermatol Ges. 2014 Apr;12(4):353-5. doi: 10.1111/ddg.12259. Epub 2014 Mar 3. No abstract available.

PMID:
24581031
22.

Epidermal expression of I-TAC (Cxcl11) instructs adaptive Th2-type immunity.

Roebrock K, Sunderkötter C, Münck NA, Wolf M, Nippe N, Barczyk K, Varga G, Vogl T, Roth J, Ehrchen J.

FASEB J. 2014 Apr;28(4):1724-34. doi: 10.1096/fj.13-233593. Epub 2014 Jan 7.

PMID:
24398292
23.

Clinical complexity of Leishmania (Viannia) braziliensis infections amongst travelers.

Eichner S, Thoma-Uszynski S, Herrgott I, Sebald H, Debus A, Tsianakas A, Ehrchen J, Harms G, Simon M, Sunderkötter C, Bogdan C.

Eur J Dermatol. 2013 Apr 1;23(2):218-23. doi: 10.1684/ejd.2013.1934.

PMID:
23557633
24.

IκBζ is a transcriptional key regulator of CCL2/MCP-1.

Hildebrand DG, Alexander E, Hörber S, Lehle S, Obermayer K, Münck NA, Rothfuss O, Frick JS, Morimatsu M, Schmitz I, Roth J, Ehrchen JM, Essmann F, Schulze-Osthoff K.

J Immunol. 2013 May 1;190(9):4812-20. doi: 10.4049/jimmunol.1300089. Epub 2013 Apr 1.

25.

[Principles of glucocorticoid therapy].

Ehrchen J.

Hautarzt. 2012 Dec;63(12):973-82; quiz 983-4. doi: 10.1007/s00105-012-2471-3. Review. German.

PMID:
23183780
26.

Beneficial effects of the melanocortin analogue Nle4-D-Phe7-α-MSH in acne vulgaris.

Böhm M, Ehrchen J, Luger TA.

J Eur Acad Dermatol Venereol. 2014 Jan;28(1):108-11. doi: 10.1111/j.1468-3083.2012.04658.x. Epub 2012 Jul 27.

PMID:
22845050
27.

CREMα overexpression decreases IL-2 production, induces a T(H)17 phenotype and accelerates autoimmunity.

Lippe R, Ohl K, Varga G, Rauen T, Crispin JC, Juang YT, Kuerten S, Tacke F, Wolf M, Roebrock K, Vogl T, Verjans E, Honke N, Ehrchen J, Foell D, Skryabin B, Wagner N, Tsokos GC, Roth J, Tenbrock K.

J Mol Cell Biol. 2012 Apr;4(2):121-3. doi: 10.1093/jmcb/mjs004. Epub 2012 Feb 20. No abstract available.

PMID:
22355096
28.

Induction of an anti-inflammatory human monocyte subtype is a unique property of glucocorticoids, but can be modified by IL-6 and IL-10.

Tsianakas A, Varga G, Barczyk K, Bode G, Nippe N, Kran N, Roth J, Luger TA, Ehrchen J, Sunderkoetter C.

Immunobiology. 2012 Mar;217(3):329-35. doi: 10.1016/j.imbio.2011.10.002. Epub 2011 Oct 20.

PMID:
22154546
29.

Subcutaneous infection with S. aureus in mice reveals association of resistance with influx of neutrophils and Th2 response.

Nippe N, Varga G, Holzinger D, Löffler B, Medina E, Becker K, Roth J, Ehrchen JM, Sunderkötter C.

J Invest Dermatol. 2011 Jan;131(1):125-32. doi: 10.1038/jid.2010.282. Epub 2010 Sep 30.

30.

Glucocorticoids promote survival of anti-inflammatory macrophages via stimulation of adenosine receptor A3.

Barczyk K, Ehrchen J, Tenbrock K, Ahlmann M, Kneidl J, Viemann D, Roth J.

Blood. 2010 Jul 22;116(3):446-55. doi: 10.1182/blood-2009-10-247106. Epub 2010 May 11.

31.

Keratinocytes determine Th1 immunity during early experimental leishmaniasis.

Ehrchen JM, Roebrock K, Foell D, Nippe N, von Stebut E, Weiss JM, Münck NA, Viemann D, Varga G, Müller-Tidow C, Schuberth HJ, Roth J, Sunderkötter C.

PLoS Pathog. 2010 Apr 29;6(4):e1000871. doi: 10.1371/journal.ppat.1000871.

32.

Revised Cutaneous Lupus Erythematosus Disease Area and Severity Index (RCLASI): a modified outcome instrument for cutaneous lupus erythematosus.

Kuhn A, Meuth AM, Bein D, Amler S, Beissert S, Böhm M, Brehler R, Ehrchen J, Grundmann S, Haust M, Ruland V, Schiller M, Schulz P, Ständer S, Sauerland C, Köpcke W, Luger TA, Bonsmann G.

Br J Dermatol. 2010 Jul;163(1):83-92. doi: 10.1111/j.1365-2133.2010.09799.x. Epub 2010 Apr 12. Erratum in: Br J Dermatol. 2010 Oct;163(4):898. Meuth, A M [added]; Bein, D [added]; Köpcke, W [added].

PMID:
20394621
33.

In vivo optical imaging of cellular inflammatory response in granuloma formation using fluorescence-labeled macrophages.

Eisenblätter M, Ehrchen J, Varga G, Sunderkötter C, Heindel W, Roth J, Bremer C, Wall A.

J Nucl Med. 2009 Oct;50(10):1676-82. doi: 10.2967/jnumed.108.060707. Epub 2009 Sep 16.

34.

Scalp necrosis in giant cell arteritis: case report and review of the relevance of this cutaneous sign of large-vessel vasculitis.

Tsianakas A, Ehrchen JM, Presser D, Fischer T, Kruse-Loesler B, Luger TA, Sunderkoetter C.

J Am Acad Dermatol. 2009 Oct;61(4):701-6. doi: 10.1016/j.jaad.2008.11.913. Epub 2009 Jul 3. Review.

PMID:
19577329
35.

The endogenous Toll-like receptor 4 agonist S100A8/S100A9 (calprotectin) as innate amplifier of infection, autoimmunity, and cancer.

Ehrchen JM, Sunderkötter C, Foell D, Vogl T, Roth J.

J Leukoc Biol. 2009 Sep;86(3):557-66. doi: 10.1189/jlb.1008647. Epub 2009 May 18. Review.

PMID:
19451397
36.

The cyclic AMP response element modulator {alpha} suppresses CD86 expression and APC function.

Ahlmann M, Varga G, Sturm K, Lippe R, Benedyk K, Viemann D, Scholzen T, Ehrchen J, Müller FU, Seidl M, Matus M, Tsokos GC, Roth J, Tenbrock K.

J Immunol. 2009 Apr 1;182(7):4167-74. doi: 10.4049/jimmunol.0802976. Erratum in: J Immunol. 2009 Jul 1;183(1):770.

37.

Calcineurin inhibitors for the treatment of atopic dermatitis.

Ehrchen J, Sunderkötter C, Luger T, Steinhoff M.

Expert Opin Pharmacother. 2008 Dec;9(17):3009-23. doi: 10.1517/14656560802498040 . Review.

PMID:
19006475
38.

Phagocyte-specific S100 proteins are released from affected mucosa and promote immune responses during inflammatory bowel disease.

Foell D, Wittkowski H, Ren Z, Turton J, Pang G, Daebritz J, Ehrchen J, Heidemann J, Borody T, Roth J, Clancy R.

J Pathol. 2008 Oct;216(2):183-92. doi: 10.1002/path.2394.

PMID:
18729068
39.

The absence of cutaneous lymph nodes results in a Th2 response and increased susceptibility to Leishmania major infection in mice.

Ehrchen JM, Roth J, Roebrock K, Varga G, Domschke W, Newberry R, Sorg C, Müller-Tidow C, Sunderkötter C, Kucharzik T, Spahn TW.

Infect Immun. 2008 Sep;76(9):4241-50. doi: 10.1128/IAI.01714-07. Epub 2008 Jul 14.

40.

Glucocorticoids induce an activated, anti-inflammatory monocyte subset in mice that resembles myeloid-derived suppressor cells.

Varga G, Ehrchen J, Tsianakas A, Tenbrock K, Rattenholl A, Seeliger S, Mack M, Roth J, Sunderkoetter C.

J Leukoc Biol. 2008 Sep;84(3):644-50. doi: 10.1189/jlb.1107768. Epub 2008 Jul 8.

PMID:
18611985
41.

Pregabalin in the treatment of chronic pruritus.

Ehrchen J, Ständer S.

J Am Acad Dermatol. 2008 Feb;58(2 Suppl):S36-7. doi: 10.1016/j.jaad.2007.07.017. No abstract available.

PMID:
18191699
42.

Vitamin D receptor signaling contributes to susceptibility to infection with Leishmania major.

Ehrchen J, Helming L, Varga G, Pasche B, Loser K, Gunzer M, Sunderkötter C, Sorg C, Roth J, Lengeling A.

FASEB J. 2007 Oct;21(12):3208-18. Epub 2007 Jun 5.

PMID:
17551101
43.

Dendritic cell-derived IL-12p40 homodimer contributes to susceptibility in cutaneous leishmaniasis in BALB/c mice.

Nigg AP, Zahn S, Rückerl D, Hölscher C, Yoshimoto T, Ehrchen JM, Wölbing F, Udey MC, von Stebut E.

J Immunol. 2007 Jun 1;178(11):7251-8.

44.

Glucocorticoids induce differentiation of a specifically activated, anti-inflammatory subtype of human monocytes.

Ehrchen J, Steinmüller L, Barczyk K, Tenbrock K, Nacken W, Eisenacher M, Nordhues U, Sorg C, Sunderkötter C, Roth J.

Blood. 2007 Feb 1;109(3):1265-74. Epub 2006 Oct 3.

45.

Site of blood vessel damage and relevance of CD18 in a murine model of immune complex-mediated vasculitis.

Sindrilaru A, Seeliger S, Ehrchen JM, Peters T, Roth J, Scharffetter-Kochanek K, Sunderkötter CH.

J Invest Dermatol. 2007 Feb;127(2):447-54. Epub 2006 Sep 28.

46.

Mitogen- and stress-activated protein kinase 1 is critical for interleukin-1-induced, CREB-mediated, c-fos gene expression in keratinocytes.

Schiller M, Böhm M, Dennler S, Ehrchen JM, Mauviel A.

Oncogene. 2006 Jul 27;25(32):4449-57. Epub 2006 Mar 13.

PMID:
16532028
47.

Expression of surfactant protein-C, S100A8, S100A9, and B cell markers in renal allografts: investigation of the prognostic value.

Eikmans M, Roos-van Groningen MC, Sijpkens YW, Ehrchen J, Roth J, Baelde HJ, Bajema IM, de Fijter JW, de Heer E, Bruijn JA.

J Am Soc Nephrol. 2005 Dec;16(12):3771-86. Epub 2005 Oct 26.

48.

The cyclic AMP response element modulator regulates transcription of the TCR zeta-chain.

Tenbrock K, Kyttaris VC, Ahlmann M, Ehrchen JM, Tolnay M, Melkonyan H, Mawrin C, Roth J, Sorg C, Juang YT, Tsokos GC.

J Immunol. 2005 Nov 1;175(9):5975-80.

49.

1alpha,25-Dihydroxyvitamin D3 is a potent suppressor of interferon gamma-mediated macrophage activation.

Helming L, Böse J, Ehrchen J, Schiebe S, Frahm T, Geffers R, Probst-Kepper M, Balling R, Lengeling A.

Blood. 2005 Dec 15;106(13):4351-8. Epub 2005 Aug 23.

50.

Senescent BALB/c mice are able to develop resistance to Leishmania major infection.

Ehrchen J, Sindrilaru A, Grabbe S, Schönlau F, Schlesiger C, Sorg C, Scharffetter-Kochanek K, Sunderkötter C.

Infect Immun. 2004 Sep;72(9):5106-14.

Supplemental Content

Loading ...
Support Center